ACP is calling for reforms to the 340B Drug Pricing Program, urging stronger oversight to ensure benefits reach vulnerable patients.
ACP is calling for reforms to the 340B Drug Pricing Program, urging stronger oversight to ensure benefits reach vulnerable patients.
